Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice

Corticosteroid Therapy for Acquired F VIII:C Inhibitors

(2010) J. A. Spero et al.   BRITISH JOURNAL OF HAEMATOLOGY

Clinical issues in inhibitors

(2010) J. ASTERMARK et al.   HAEMOPHILIA

Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review

(2010) A. IORIO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Safety of Recombinant Activated Factor VII in Randomized Clinical Trials

(2010) Marcel Levi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prophylaxis in Congenital Hemophilia with Inhibitors: The Role of Recombinant Activated Factor VII

(2010) Massimo Franchini et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

The Multifactorial Etiology of Inhibitor Development in Hemophilia: Genetics and Environment

(2010) Samantha Gouw et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Laboratory Identification of Factor Inhibitors: The Perspective of a Large Tertiary Hemophilia Center

(2010) Geoffrey Kershaw et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Recombinant Activated Factor VII: Mechanisms of Action and Current Indications

(2010) Massimo Franchini et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Systematic review of efficacy of rFVIIa and aPCC treatment for hemophilia patients with inhibitors

(2009) Chris Knight et al.   ADVANCES IN THERAPY

Advances in the understanding of acquired haemophilia A: implications for clinical practice

(2009) Peter W. Collins et al.   BRITISH JOURNAL OF HAEMATOLOGY

International recommendations on the diagnosis and treatment of patients with acquired hemophilia A

(2009) A. Huth-Kuhne et al.   HAEMATOLOGICA

The North American Immune Tolerance Registry: contributions to the thirty-year experience with immune tolerance therapy

(2009) D. DIMICHELE   HAEMOPHILIA

Efficacy of recombinant activated factor VII vs. activated prothrombin complex concentrate for patients suffering from haemophilia complicated with inhibitors: a Bayesian meta-regression

(2009) M. J. TREUR et al.   HAEMOPHILIA

Extracorporeal Immunoadsorption for the Treatment of Coagulation Inhibitors

(2009) Massimo Franchini et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Acquired factor VIII inhibitors

(2008) M. Franchini et al.   BLOOD

Laboratory, clinical and therapeutic aspects of acquired hemophilia A

(2008) Massimo Franchini et al.   CLINICA CHIMICA ACTA

Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors

(2008) K. FISCHER et al.   HAEMOPHILIA

Immune tolerance with rituximab in congenital haemophilia with inhibitors: a systematic literature review based on individual patients’ analysis

(2008) M. FRANCHINI et al.   HAEMOPHILIA

Single 270 μg kg−1-dose rFVIIa vs. standard 90 μg kg−1-dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison

(2008) G. YOUNG et al.   HAEMOPHILIA

Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors

(2008) W. K. HOOTS et al.   HAEMOPHILIA

Back to the future: a recent history of haemophilia treatment

(2008) P. M. MANNUCCI   HAEMOPHILIA

International survey of attitudes towards secondary prophylaxis with recombinant factor VIIa in haemophilia A patients with inhibitors

(2008) P. M. MANNUCCI et al.   HAEMOPHILIA